Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2018 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2018) Vol. 14, Iss. 3, pp. 367-429
Closed Access | Times Cited: 1800

Showing 1-25 of 1800 citing articles:

Ageing as a risk factor for neurodegenerative disease
Yujun Hou, Xiuli Dan, Mansi Babbar, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 10, pp. 565-581
Closed Access | Times Cited: 2374
2019 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2019) Vol. 15, Iss. 3, pp. 321-387
Closed Access | Times Cited: 2170
2020 Alzheimer's disease facts and figures
In this phase, individuals have measurable brain changes that indicate the earliest signs of Alzheimer's disease, but they have not yet developed symptoms such as memory loss. Examples of measurable brain changes …, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 3, pp. 391-460
Open Access | Times Cited: 2142
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Fangda Leng, Paul Edison
Nature Reviews Neurology (2020) Vol. 17, Iss. 3, pp. 157-172
Closed Access | Times Cited: 2059
2023 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2023) Vol. 19, Iss. 4, pp. 1598-1695
Open Access | Times Cited: 2000
2022 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2022) Vol. 18, Iss. 4, pp. 700-789
Closed Access | Times Cited: 1970
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yu Yamazaki, Na Zhao, Thomas R. Caulfield, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 9, pp. 501-518
Open Access | Times Cited: 1036
Gender inequality and restrictive gender norms: framing the challenges to health
Lori Heise, Margaret E. Greene, Neisha Opper, et al.
The Lancet (2019) Vol. 393, Iss. 10189, pp. 2440-2454
Closed Access | Times Cited: 822
A single-cell atlas of entorhinal cortex from individuals with Alzheimer’s disease reveals cell-type-specific gene expression regulation
Alexandra Grubman, Gabriel Chew, John F. Ouyang, et al.
Nature Neuroscience (2019) Vol. 22, Iss. 12, pp. 2087-2097
Closed Access | Times Cited: 780
Neuroinflammation as a Common Feature of Neurodegenerative Disorders
Leonardo Guzmán‐Martínez, Ricardo B. Maccioni, Víctor Andrade, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 584
2024 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3708-3821
Open Access | Times Cited: 561
Deep Learning in Alzheimer's Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data
Taeho Jo, Kwangsik Nho, Andrew J. Saykin
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 542
Anticholinergic Drug Exposure and the Risk of Dementia
Carol Coupland, Trevor Hill, Tom Dening, et al.
JAMA Internal Medicine (2019) Vol. 179, Iss. 8, pp. 1084-1084
Open Access | Times Cited: 489
The Alzheimer’s Disease Clinical Spectrum
Alireza Atri
Medical Clinics of North America (2019) Vol. 103, Iss. 2, pp. 263-293
Open Access | Times Cited: 455
<p>Alzheimer’s Disease – Why We Need Early Diagnosis</p>
J Rasmussen, Haya Langerman
Degenerative Neurological and Neuromuscular Disease (2019) Vol. Volume 9, pp. 123-130
Open Access | Times Cited: 345
Association Between Sleep Duration and Cognitive Decline
Yanjun Ma, Lirong Liang, Fanfan Zheng, et al.
JAMA Network Open (2020) Vol. 3, Iss. 9, pp. e2013573-e2013573
Open Access | Times Cited: 343
Alzheimer’s disease and its treatment by different approaches: A review
Sukriti Srivastava, Razi Ahmad, Sunil Kumar Khare
European Journal of Medicinal Chemistry (2021) Vol. 216, pp. 113320-113320
Closed Access | Times Cited: 336
A Deep Learning Approach for Automated Diagnosis and Multi-Class Classification of Alzheimer’s Disease Stages Using Resting-State fMRI and Residual Neural Networks
Farheen Ramzan, Muhammad Usman Ghani Khan, Asim Rehmat, et al.
Journal of Medical Systems (2019) Vol. 44, Iss. 2
Closed Access | Times Cited: 330
New Insights Into the Pathogenesis of Alzheimer's Disease
Liyuan Fan, Chengyuan Mao, Xinchao Hu, et al.
Frontiers in Neurology (2020) Vol. 10
Open Access | Times Cited: 288
From Diagnosis to Treatment: Recent Advances in Patient-Friendly Biosensors and Implantable Devices
Pei Li, Gunhee Lee, Su Yeong Kim, et al.
ACS Nano (2021) Vol. 15, Iss. 2, pp. 1960-2004
Closed Access | Times Cited: 279
Defining Cognitive Reserve and Implications for Cognitive Aging
Corinne Pettigrew, Anja Soldan
Current Neurology and Neuroscience Reports (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 274
The Role of Magnesium in Neurological Disorders
Anna E. Kirkland, Gabrielle L. Sarlo, Kathleen F. Holton
Nutrients (2018) Vol. 10, Iss. 6, pp. 730-730
Open Access | Times Cited: 267
Alzheimer’s Disease: Treatment Strategies and Their Limitations
Elodie Passeri, Kamil Elkhoury, Margaretha Morsink, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13954-13954
Open Access | Times Cited: 255
The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease
Martí Colom‐Cadena, Tara L. Spires‐Jones, Henrik Zetterberg, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 247
BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
Nour M. Moussa‐Pacha, Shifaa M. Abdin, Hany A. Omar, et al.
Medicinal Research Reviews (2019) Vol. 40, Iss. 1, pp. 339-384
Open Access | Times Cited: 245
Page 1 - Next Page

Scroll to top